PS
Patel Samir Rashmikant
OFFICER
内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Patel Samir Rashmikant. Insider active across 1 company, notably Akari Therapeutics Plc. In total, 13 filings have been published. History available since 31 May 2024. The latest transaction was disclosed on 7 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Patel Samir Rashmikant
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
1,209 股@ US$8.00American Depositary Shares representing Ordinary SharesSEC:0001493152-26-033634:0
15,466 股@ US$0.0004American Depositary Shares representing Ordinary SharesSEC:0001493152-26-033634:1
5,799 股@ US$0.0004American Depositary Shares representing Ordinary SharesSEC:0001493152-26-033634:2
406,250 股@ US$1.1221.0% 占其流量American Depositary Shares representing Ordinary SharesSEC:0000950170-25-036486:0
208,000 股@ US$0.00060.0% 占其流量Ordinary Shares, par value $0.0001 per shareSEC:0000950170-25-002864:0
3,200,000 股@ US$0.00050.1% 占其流量Ordinary Shares, par value $0.0001 per shareSEC:0000950170-24-141162:0
7,500,000 股@ US$0.00050.2% 占其流量Ordinary Shares, par value $0.0001 per shareSEC:0000950170-24-140807:0
1,400,000 股@ US$0.00050.0% 占其流量Ordinary Shares, par value $0.0001 per shareSEC:0000950170-24-140427:0
1,400,000 股@ US$0.00050.0% 占其流量Ordinary Shares, par value $0.0001 per shareSEC:0000950170-24-140430:0
419,286,000 股@ US$0.001223.8% 占其流量Ordinary Shares, par value $0.0001 per shareSEC:0000950170-24-132936:0
1,404,622,000 股Ordinary Shares, par value $0.0001 per shareSEC:0000950170-24-128190:0
91,396,000 股0Ordinary Shares, par value $0.0001 per shareSEC:0000950170-24-080542:0
1,326,258,000 股@ US$0.000954.9% 占其流量Ordinary Shares, par value $0.0001 per shareSEC:0000950170-24-068771:0
About Patel Samir Rashmikant
Patel Samir Rashmikant is a Director at Akari Therapeutics Plc (XNAS). He has 10 filings in total, and the 10 sampled filings run from 2024-06-04 to 2025-03-10, with transactions of Attribution nature and buy and sell amounts of EUR 0.